(HPD) is a Cluster B personality disorder defined by pervasive attention-seeking, excessive emotionality, and dramatic interpersonal behavior beginning by early adulthood. retains HPD as a categorical diagnosis under the general personality-disorder framework, while the Alternative Model for Personality Disorders (AMPD) in Section III and have shifted toward dimensional trait-based formulations that omit a standalone histrionic category. Clinical recognition matters because HPD is frequently misread as , , or simple "difficult" patient behavior, and because it carries elevated rates of mood, anxiety, somatic-symptom, and substance use comorbidity. No medication is FDA-approved for HPD itself; psychodynamic and cognitive-behavioral psychotherapies are the foundation of care, with pharmacotherapy reserved for comorbid syndromes. Bottom line: HPD is a stable, trait-level disorder of self-presentation and interpersonal regulation whose accurate diagnosis depends on differentiating it from overlapping Cluster B conditions and from culturally normative expressiveness.
HPD is one of the less common personality disorders in community samples, though it appears more often in clinical settings where attention-seeking and somatic complaints drive help-seeking. Prevalence estimates vary widely with assessment method and diagnostic edition.
Prevalence and demographics
- Lifetime community prevalence is approximately 1.84% in the U.S. National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).[1]
- DSM-5-TR reports a similar general-population prevalence consistent with NESARC data.[2]
- Earlier DSM editions reported a strong female preponderance, but structured-interview data from NESARC show comparable rates between men and women when assessment is standardized.[1-2]
- Onset is by early adulthood by definition; the diagnosis is not made before age 18, and traits often attenuate after midlife.[2-3]
Comorbidity
- High co-occurrence with other Cluster B personality disorders, particularly borderline, narcissistic, and antisocial.[1,3]
- Elevated rates of major depressive disorder, , and .[1,3]
- Increased prevalence of somatic symptom disorder, conversion (functional neurological) disorder, and illness anxiety disorder.[2-3]
- Substance use disorders, particularly , are common.[1]
Risk factors
- Heritable contribution from broader Cluster B and externalizing traits; HPD-specific twin data are limited.[3]
- Early-life environments characterized by inconsistent parental attention or reinforcement of dramatic emotional expression are associated with later histrionic traits, though causal inference is limited.[3]
HPD lacks a specific neurobiological signature. It is best understood within broader models of Cluster B personality pathology emphasizing temperament, , and reinforcement learning.
Neurobiology
- No reliably replicated structural or functional imaging finding is specific to HPD.[3]
- Shared dimensional substrates with other Cluster B disorders include altered processing in limbic-prefrontal circuits implicated in emotion regulation and reward sensitivity.[3]
- Trait-level associations with high extraversion and high neuroticism (Five-Factor Model) overlap substantially with histrionic features.[3]
Genetics
- Personality disorders broadly show moderate heritability, but HPD-specific heritability estimates are imprecise due to small samples and diagnostic overlap.[3,7]
- No replicated findings specific to HPD have been reported.[7]
Psychological and developmental models
- Psychodynamic formulations emphasize unresolved oedipal-phase conflicts, identification with caregivers who reinforced performance over autonomy, and use of repression and dissociation as primary defenses.[4]
- Cognitive models describe core beliefs such as "I must be the center of attention to feel worthwhile" and "my feelings should guide my actions," generating impressionistic thinking and approval-contingent self-worth.[5]
- Interpersonal-learning models emphasize early reinforcement of dramatic emotional display as the most reliable route to caregiver attention.[3-4]
DSM-5-TR places HPD in the Cluster B ("dramatic, emotional, erratic") group within the categorical personality disorder framework. The diagnosis requires a pervasive pattern of excessive emotionality and attention-seeking beginning by early adulthood and present across contexts.
DSM-5-TR criteria (paraphrased)
- A pervasive pattern of excessive emotionality and attention-seeking, beginning by early adulthood and present in a variety of contexts, indicated by five or more of the following:[2]
- Discomfort in situations where the person is not the center of attention.[2]
- Interaction with others characterized by inappropriate sexually seductive or provocative behavior.[2]
- Rapidly shifting and shallow expression of emotions.[2]
- Consistent use of physical appearance to draw attention to self.[2]
- Speech that is excessively impressionistic and lacking in detail.[2]
- Self-dramatization, theatricality, and exaggerated expression of emotion.[2]
- Suggestibility (easily influenced by others or circumstances).[2]
- Considers relationships to be more intimate than they actually are.[2]
- General personality disorder criteria must also be met: enduring pattern deviating markedly from cultural expectations, manifesting in cognition, affectivity, interpersonal functioning, or impulse control; inflexible and pervasive; onset traceable to adolescence or early adulthood; not better explained by another mental disorder, substance, or medical condition.[2]
Specifiers and modifiers
- DSM-5-TR does not assign severity specifiers, course modifiers, or subtype specifiers to HPD in the categorical Section II framework.[2]
- The DSM-5-TR Section III Alternative Model for Personality Disorders (AMPD) does not retain HPD as a named type; histrionic features are captured by the traits of emotional lability, attention-seeking, and manipulativeness in the negative-affectivity and antagonism domains.[2]
ICD-11 differences
- ICD-11 eliminated discrete personality disorder categories and replaced them with a single personality disorder diagnosis specified by severity (mild, moderate, severe) and prominent trait domains (negative affectivity, detachment, dissociality, disinhibition, anankastia) plus an optional qualifier.[6]
- Histrionic features in ICD-11 are coded through combinations of negative affectivity (emotional lability) and dissociality (attention-seeking, self-centeredness).[6]
Patients with HPD typically present as warm, engaging, and dramatic on initial contact, with rapid rapport but shallow content. Emotional expression is colorful and labile, while substantive detail is scarce.
Core interpersonal style
- Attention-seeking is the cardinal feature; discomfort or distress arises when the patient is not the center of focus.[2-3]
- Seductiveness, flirtatiousness, or provocative behavior across contexts (including clinical encounters) where it is inappropriate.[2-3]
- Rapid shifts between strong emotions that observers perceive as shallow or performative.[2-3]
- Overestimation of intimacy in casual relationships, sometimes referring to brief acquaintances as close friends.[2]
Cognitive and communication style
- lacking detail: opinions stated forcefully without supporting specifics.[2,5]
- Suggestibility and reliance on intuition rather than analysis when making decisions.[2,5]
- Self-image tied closely to others' reactions; difficulty tolerating disapproval or perceived neglect.[3-4]
Course
- Traits emerge by adolescence or early adulthood and are typically stable through the third and fourth decades.[2-3]
- Attenuation of overt dramatic behavior is common after midlife, though core interpersonal patterns often persist.[3]
- Functional impairment is most evident in intimate relationships and occupational settings requiring sustained, detail-oriented work.[3]
Red flags during evaluation
- Rapid idealization of the clinician on first visit followed by devaluation when limits are set.[3-4]
- Inappropriate seductiveness toward clinicians of either sex; document carefully and maintain frame.[3]
- Suicidal gestures or self-harm in response to interpersonal stress; assess seriously despite apparent dramatic quality.[3]
Histrionic features overlap substantially with other Cluster B disorders and with several Axis I conditions; careful longitudinal and cross-sectional comparison is required.
Cluster B and other personality disorders
- Borderline personality disorder (BPD) shares attention-seeking and emotional lability but is distinguished by identity disturbance, chronic emptiness, recurrent self-harm or suicidality, frantic efforts to avoid abandonment, and paranoid or dissociative symptoms under stress.[2-3]
- (NPD) shares the need for admiration but emphasizes grandiosity, entitlement, and lack of empathy rather than emotional theatricality and suggestibility.[2-3]
- shares manipulativeness and superficial charm but features deceit for personal gain, disregard for others' rights, and a documented conduct-disorder history before age 15.[2]
- shares suggestibility and reassurance-seeking but is characterized by submissiveness and fear of separation rather than dramatic display.[2]
| Feature | Histrionic PD | Borderline PD | Narcissistic PD |
|---|---|---|---|
| Core driver | Need to be center of attention | Fear of abandonment, identity disturbance | Need for admiration, grandiosity |
| Onset and course | Early adulthood, stable, attenuates after midlife | Early adulthood, often improves with age | Early adulthood, often stable |
| Affect | Shallow, rapidly shifting | Intense, unstable, chronic emptiness | Reactive to perceived slights |
| Self-image | Approval-dependent | Markedly unstable | Inflated, fragile |
| Self-harm | Gestures possible, less chronic | Recurrent self-harm and suicidality | Uncommon outside narcissistic injury |
| First-line management | Psychodynamic or CBT psychotherapy | DBT or MBT psychotherapy |
Axis I and medical conditions
- Bipolar disorder (especially type II and cyclothymia) can mimic emotional lability; HPD lacks discrete mood episodes with sustained changes in sleep, energy, and goal-directed activity.[2-3]
- Persistent depressive disorder and major depressive disorder may co-occur and should be assessed independently.[1,3]
- Substance intoxication (stimulants, alcohol) can produce transient histrionic-appearing behavior; diagnose only when traits are present outside intoxication.[2]
- Hyperthyroidism, frontal-lobe lesions, and temporal-lobe epilepsy can produce emotional dysregulation and disinhibition that mimic personality pathology; screen with TSH and a focused neurological exam when onset is late or atypical.[3]
- Histrionic-appearing presentations in the context of conversion (functional neurological) disorder require careful separation: comorbidity is common, but functional neurological symptoms are not themselves diagnostic of HPD.[2-3]
Cultural considerations
- Expressiveness, gesture, and emotional display vary widely across cultures; the diagnosis requires that the pattern deviate markedly from cultural norms and cause impairment or distress.[2]
Diagnosis is clinical, based on longitudinal history and observation across multiple visits. No laboratory or imaging finding establishes the diagnosis.
Interview approach
- Establish a stable therapeutic frame from the first visit, including clear limits on session length, communication between visits, and physical boundaries.[3-4]
- Collect collateral information from family or longstanding partners; self-report alone is unreliable due to impressionistic recall.[3]
- Probe for specifics behind dramatic statements ("He was the most amazing person ever" → "What did he do that stood out?") to elicit the characteristic lack of detail.[3,5]
- Screen explicitly for self-harm, suicidality, and somatic-symptom presentations at every visit during the assessment phase.[3]
Validated instruments
- (SCID-5-PD) is the reference-standard categorical interview.[9]
- International Personality Disorder Examination (IPDE) provides parallel coding for DSM and ICD systems.[10]
- (PID-5) is a self-report measure of the AMPD trait domains useful when a dimensional formulation is needed.[2]
- Millon Clinical Multiaxial Inventory (MCMI-IV) is a commonly used self-report screen that includes a histrionic scale.[3]
Physical examination and laboratory work-up
- A focused medical evaluation is appropriate when traits emerge late, change abruptly, or are accompanied by neurological signs.[3]
- TSH, comprehensive metabolic panel, and toxicology screen are reasonable when mood lability or behavioral change is acute.[3]
- Neuroimaging is not routine; reserve for new focal signs, cognitive decline, or late-onset behavioral change.[3]
- Do not order projective psychological testing as a primary diagnostic tool; it is not validated for categorical personality disorder diagnosis.[3]
No medication is FDA-approved for HPD itself, and no large randomized trial has tested any psychotherapy specifically in HPD samples. Treatment is extrapolated from the broader personality disorder evidence base and targets functional impairment, interpersonal patterns, and comorbid syndromes.
Pharmacotherapy
- It is uncertain whether any pharmacologic agent modifies the core histrionic personality structure; no medication has demonstrated efficacy for HPD as a primary indication.[3,11]
- Some experts recommend treating comorbid major depressive disorder, persistent depressive disorder, or anxiety disorders with standard agents such as sertraline 50 mg PO QD or fluoxetine 20 mg PO QD, though high-quality evidence in HPD samples is lacking.[3,11]
- Limited evidence supports short-course low-dose antipsychotics or for severe affective lability in Cluster B disorders broadly; the data in HPD specifically are very low quality.[11]
- Avoid as standing treatment given high comorbidity with substance use disorders and the reinforcement of dramatic crisis presentations.[3,11]
Psychotherapy
- Psychotherapy is the foundation of HPD treatment; the strongest evidence base across personality disorders supports structured, time-limited, manualized therapies.[3-4,8]
- Psychodynamic psychotherapy, including and supportive-expressive variants, is commonly recommended and targets defensive patterns, identification, and approval-contingent self-worth.[4]
- Cognitive-behavioral therapy targets impressionistic thinking and the core belief that emotional display is required to secure attention; evidence in HPD specifically is limited.[5]
- (DBT) skills training (emotion regulation, interpersonal effectiveness, distress tolerance) is often borrowed for HPD patients with prominent affective lability, although the trial evidence base is in BPD.[8]
- Group therapy can be useful but carries risk of the patient dominating sessions; combined individual-plus-group formats with explicit group norms are commonly recommended.[3-4]
Neuromodulation
- No indication for , , or other neuromodulation in HPD itself.[3]
- Treat comorbid conditions (e.g., ) according to their own evidence base.[3]
Adjunctive
- Couples or family therapy is commonly recommended when interpersonal patterns are reinforced within an enmeshed family system.[3-4]
- Coordinated care among primary care, psychiatry, and psychotherapy reduces fragmented prescribing and emergency-department reliance.[3]
- Address comorbid substance use disorders with standard evidence-based treatments; do not defer until "personality work" is complete.[3,11]
| Intervention | Evidence base/Comparator | Benefits | Harms | Certainty | Notes |
|---|---|---|---|---|---|
| Psychodynamic psychotherapy | Trials in mixed personality disorder samples; HPD-specific RCTs absent[4] | Improved interpersonal function, reduced symptom distress[4] | Long duration, cost, regression risk[4] | low | Most established framework for HPD specifically[4] |
| Cognitive-behavioral therapy | Trials in mixed Cluster B samples[5] | Targets impressionistic cognition, approval-contingent beliefs[5] | Limited engagement when emotional expression is the patient's primary reward[5] | low | Reasonable alternative when psychodynamic therapy is unavailable[5] |
| DBT skills modules | RCT evidence in BPD, extrapolated[8] | Emotion regulation, interpersonal effectiveness skills[8] | Trial data not specific to HPD[8] | very_low | Useful adjunct for affective lability[8] |
| SSRI for comorbid MDD or anxiety | Standard MDD/anxiety RCT evidence[11] | Reduces comorbid mood and anxiety burden[11] | Sexual side effects, discontinuation symptoms[11] | moderate | Treats comorbidity, not HPD itself[11] |
| Antipsychotics or mood stabilizers | Small trials in Cluster B broadly[11] | Possible reduction in affective lability and impulsivity[11] | Metabolic, extrapyramidal, teratogenic risks[11] | very_low | Reserve for severe, refractory presentations[11] |
Risk in HPD comes more from the disorder's interpersonal consequences and from iatrogenic harm than from any specific therapy. The evidence base is thin and largely indirect.
Adverse effects of pharmacotherapy
- SSRI-related sexual dysfunction, gastrointestinal upset, and discontinuation symptoms can amplify somatic preoccupation in HPD patients.[11]
- Antipsychotic-related metabolic , sedation, and accumulate quickly with off-label, long-term use.[11]
- Benzodiazepines carry tolerance, dependence, and disinhibition risk in a population already prone to dramatic crises.[3,11]
Iatrogenic and frame harms
- Excessive accommodation of dramatic presentations (frequent unscheduled contacts, escalating prescriptions, repeated emergency-department referrals) reinforces the pattern.[3-4]
- Boundary violations by clinicians (lengthened sessions, personal disclosure, physical contact) cause measurable harm and should be prevented by explicit frame maintenance and supervision.[3-4]
Limitations of the evidence base
- No randomized controlled trial has tested any treatment in a population defined by DSM HPD as the primary diagnosis.[3-4]
- Most data derive from mixed Cluster B or BPD samples and are extrapolated to HPD with low confidence.[3-4,8]
- The dimensional reformulation in DSM-5-TR Section III and ICD-11 means future trials are unlikely to use categorical HPD as an entry criterion, further limiting direct evidence.[6-7]
Histrionic traits present and evolve differently across the life span and across medical contexts, and standard treatment must be tailored accordingly.
Pediatric and adolescent
- DSM-5-TR does not permit a personality disorder diagnosis before age 18 except in unusual circumstances with stable, pervasive traits present for at least one year.[2]
- Adolescents with prominent attention-seeking, dramatic affect, and impressionistic cognition should be assessed for emerging Cluster B traits and treated with family-inclusive psychotherapy.[3]
Geriatric
- Overt dramatic behavior often attenuates in later life, but interpersonal patterns and approval-dependence frequently persist.[3]
- New-onset histrionic-appearing behavior in older adults should prompt evaluation for , vascular cognitive change, delirium, or medication effects.[3]
Perinatal
- Pregnancy and the postpartum period can amplify both dramatic presentations and somatic preoccupation; coordinate obstetric, primary care, and psychiatric care closely.[3]
- When are indicated for comorbid depression or anxiety, follow standard perinatal prescribing guidance and document risk-benefit discussions.[11]
Comorbid medical illness
- Somatic symptom disorder, conversion (functional neurological) disorder, and illness anxiety disorder co-occur frequently and may dominate the presentation.[2-3]
- Coordinate with primary care and relevant specialties; avoid both excessive workup and premature dismissal of physical complaints.[3]
Comorbid substance use
- Alcohol use disorder is the most common substance comorbidity and should be addressed with standard evidence-based interventions rather than deferred.[1,11]
Cultural considerations
- Expressiveness, gesture, dress, and emotional display vary widely across cultures; the diagnosis requires deviation from the individual's own cultural norms and accompanying impairment.[2]
HPD is a chronic, trait-level condition with variable functional outcomes. Long-term naturalistic data specific to HPD are limited.
Natural history
- Traits are typically evident by adolescence or early adulthood and remain relatively stable through the third and fourth decades.[2-3]
- Overt dramatic behavior often attenuates after midlife, while approval-dependence and impressionistic cognition tend to persist.[3]
Response and outcome
- Symptomatic improvement with structured psychotherapy is reported in mixed personality disorder samples; HPD-specific response rates are not well established.[3-4]
- Functional improvement (occupational stability, partnered relationships, reduced healthcare utilization) is the most clinically meaningful outcome.[3]
Suicide and mortality
- Suicidal gestures occur in the context of interpersonal stress and should be assessed seriously despite their apparent dramatic quality.[3]
- Completed suicide is less well characterized in HPD than in BPD; HPD-specific mortality data are limited.[3]
- Comorbid major depressive disorder, substance use disorder, and BPD substantially increase suicide risk and should be treated aggressively.[1,3]
Emergency presentations in HPD typically arise from interpersonal crises rather than from primary mood, psychotic, or substance episodes. They require structured assessment without escalation.
Hospitalization criteria
- Acute suicidal intent with a plan, inability to maintain safety, or comorbid severe depression with neurovegetative features.[3]
- Avoid hospitalization for repeated low-lethality gestures without acute risk, as inpatient admission can reinforce dramatic crisis presentations.[3]
Suicide risk assessment
- Conduct a standard structured suicide risk assessment at every emergency presentation; do not discount risk because of dramatic style.[3]
- Comorbid BPD, major depressive disorder, and substance use disorder are the strongest risk amplifiers.[1,3]
Agitation and frame management
HPD sits near the center of ongoing debates about whether personality disorders should be diagnosed categorically at all. Several controversies are clinically relevant.
Categorical versus dimensional classification
- The DSM-5-TR Section III AMPD and ICD-11 dimensional system omit HPD as a discrete category, capturing histrionic features through trait domains instead.[2,6]
- Critics argue HPD shows poor incremental validity beyond BPD and NPD and high diagnostic overlap; defenders argue the categorical label still communicates clinically useful patterns.[6-7]
Sex and gender bias
- Historical claims of strong female preponderance have not held up in structured-interview epidemiology, raising concerns that prior diagnostic criteria and clinical practice reflected gendered stereotypes of emotional expression.[1,7]
- Clinicians should apply criteria identically across sex and gender and document specific behaviors rather than impressions.[2,7]
Evidence-base limitations
- Histrionic personality disorder requires five or more of eight DSM-5-TR criteria, with pervasive attention-seeking and excessive emotionality beginning by early adulthood.[2]
- HPD is a Cluster B ("dramatic, emotional, erratic") personality disorder alongside borderline, narcissistic, and antisocial.[2]
- Personality disorders are generally not diagnosed before age 18 except in unusual circumstances with stable traits present at least one year.[2]
- The mnemonic PRAISE ME captures the eight DSM-5-TR criteria for HPD.[2]
- Structured-interview epidemiology shows similar HPD prevalence in men and women, contradicting earlier female-preponderance claims.[1-2]
- BPD is distinguished from HPD by identity disturbance, chronic emptiness, recurrent self-harm, and fear of abandonment.[2]
- NPD is distinguished from HPD by grandiosity and entitlement rather than theatrical emotionality and suggestibility.[2]
- No medication is FDA-approved for HPD; pharmacotherapy targets comorbid mood, anxiety, or substance use disorders.[3,11]
- Psychodynamic psychotherapy and cognitive-behavioral therapy are the commonly recommended first-line treatments, with low-certainty evidence.[3-5]
- ICD-11 abolished discrete personality disorder categories in favor of a single diagnosis with severity and trait-domain specifiers.[6]
- DSM-5-TR Section III AMPD does not retain HPD as a named type.[2]
- Somatic symptom disorder, conversion disorder, and illness anxiety disorder are common comorbidities.[2-3]
- Suicidal statements in HPD must be assessed with standard rigor; dramatic delivery does not predict lethality.[3]
- Benzodiazepines should generally be avoided as standing treatment due to substance use comorbidity and reinforcement of crisis presentations.[3,11]
- New-onset histrionic-appearing behavior in older adults should prompt evaluation for frontotemporal dementia or other neurological disease.[3]
No external funding. No conflicts of interest declared. Peer-review status: pending.
- 1.Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2004;65(7):948-958. doi:10.4088/jcp.v65n0711. PMID: 15291684.PMID: 15291684doi:10.4088/jcp.v65n0711
- 2.TextbookAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text rev. Washington, DC: American Psychiatric Association Publishing; 2022.
- 3.TextbookSadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 11th ed. Philadelphia: Wolters Kluwer; 2015.
- 4.TextbookGabbard GO. Psychodynamic Psychiatry in Clinical Practice. 5th ed. Washington, DC: American Psychiatric Publishing; 2014.
- 5.TextbookBeck AT, Davis DD, Freeman A, editors. Cognitive Therapy of Personality Disorders. 3rd ed. New York: Guilford Press; 2015.
- 6.TextbookWorld Health Organization. International Classification of Diseases, Eleventh Revision (ICD-11). Geneva: WHO; 2019. https://icd.who.int/. Accessed May 17, 2026.Link
- 7.Tyrer P, Reed GM, Crawford MJ. Classification, assessment, prevalence, and effect of personality disorder. Lancet. 2015;385(9969):717-726. doi:10.1016/S0140-6736(14)61995-4. PMID: 25706217.PMID: 25706217doi:10.1016/S0140-6736(14)61995-4
- 8.TextbookLinehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York: Guilford Press; 1993.
- 9.TextbookFirst MB, Williams JBW, Benjamin LS, Spitzer RL. Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD). Arlington, VA: American Psychiatric Association Publishing; 2016.
- 10.Loranger AW. International Personality Disorder Examination (IPDE): DSM-IV and ICD-10 Modules. Odessa, FL: Psychological Assessment Resources; 1999.
- 11.TextbookStahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge: Cambridge University Press; 2021.
More on these topics
Obsessive-Compulsive Personality Disorder (OCPD): Diagnosis, Differential, and Evidence-Based Management
A clinical reference on OCPD covering DSM-5-TR criteria, differentiation from OCD, assessment, and evidence-based treatment.
Obsessive-Compulsive Personality DisorderPersonality DisordersDependent Personality Disorder: Diagnosis, Differential, and Management
Evidence-based overview of dependent personality disorder for clinicians: DSM-5-TR criteria, differential diagnosis, assessment, and psychotherapy-first treatment.
Dependent Personality DisorderPersonality DisordersAvoidant Personality Disorder: Diagnosis, Differential, and Evidence-Based Management
A clinical reference on avoidant personality disorder covering DSM-5-TR diagnosis, differentiation from social anxiety disorder, and evidence-based treatment.
Avoidant Personality DisorderPersonality DisordersNarcissistic Personality Disorder: Diagnosis, Differential, and Evidence-Based Management
A clinical reference on narcissistic personality disorder covering DSM-5-TR criteria, differential diagnosis, assessment, and psychotherapy-led management.
Narcissistic Personality DisorderPersonality DisordersBorderline Personality Disorder: Diagnosis, Evidence-Based Treatment, and Clinical Management
A clinical reference on borderline personality disorder covering DSM-5-TR diagnosis, differential, evidence-based psychotherapies, and pharmacologic adjuncts.
Borderline Personality DisorderPersonality DisordersAntisocial Personality Disorder: Diagnosis, Assessment, and Management
Clinical reference on antisocial personality disorder covering DSM-5-TR criteria, differential diagnosis, evidence-based treatment, and forensic considerations.
Antisocial Personality DisorderPersonality DisordersSchizotypal Personality Disorder: Diagnosis, Differential, and Management
Clinical overview of schizotypal personality disorder, covering DSM-5-TR criteria, schizophrenia-spectrum biology, differential, and evidence-based management.
Schizotypal Personality DisorderPersonality DisordersSchizoid Personality Disorder: Diagnosis, Differential, and Management
A clinical review of schizoid personality disorder: DSM-5-TR criteria, differential diagnosis, assessment, and evidence-based management.
Schizoid Personality DisorderPersonality Disorders